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Recently we reported that DNA of the human oncogenic papillomaviruses (HPV) and the tumor suppressive human helper
virus-dependent parvoviruses, adeno-associated viruses type 2 (AAV-2), colocalize in cervical epithelium. To analyze whether
infectious AAV particles are present in cervical tissue, we examined cervical biopsies from 36 patients with HPV-related
lesions (squamous intraepithelial lesions) for the presence of AAV DNA and of infectious AAV. From each patient specimens
from the lesion and from adjacent normal epithelium were analyzed. After PCR analysis AAV DNA-containing samples were
purified by CsCl gradient centrifugation. The presence of AAV virions in CsCl gradients was analyzed and infectivity of AAV
was determined. In addition, the biopsies were tested for the presence of HPV DNA. AAV DNA could be detected in biopsies
from 23 of 36 patients. AAV particles were found in 11 AAV DNA-positive biopsies from 7 patients (lesions and/or normal
tissue, respectively). AAV particles were found to be infectious virions in 10 of the 11 cases. These results demonstrate for
the first time that infectious AAV can be isolated from human cervical biopsies, indicating a possible sexual transmission of
AAV. © 1998 Academic Press
INTRODUCTION
Recent studies have demonstrated the presence of
DNA of the human helpervirus-dependent parvovirus
(AAV-2) in biopsies of uterus tissues of many women
(Tobiasch et al., 1994; Walz et al., 1997; Friedman-Einat et
al., 1997). Together with the detection of AAV DNA in
cervical brushings (Han et al., 1996), these findings sug-
gest a possible sexual transmission of AAV. On the other
hand, approximately one-third of all human papillomavi-
ruses (HPV) infect the mucosal epithelium of the ano-
genital region (Nuovo et al., 1991) and a subset of these,
including types 16, 18, 31, 33, and 45, are associated with
over 95% of all cervical cancers (zur Hausen, 1987; zur
Hausen, 1991; Gissmann, 1992).
In contrast to HPV, infection by AAV is negatively as-
sociated with cancer development, notably cervical can-
cer (Mayor et al., 1976). AAV infection has been reported
to inhibit tumor growth of cervix carcinoma cell lines in
vivo (Walz et al., 1992; Su and Wu, 1996). In addition, AAV
has been shown to inhibit oncogenic functions of HPV in
vitro (Hermonat, 1994; Hermonat et al., 1997).
Furthermore, we could show that HPV can provide
helper functions for AAV in vitro, inducing replication of
AAV DNA and in some cases production of infectious
progeny viruses (Walz et al., 1997). A possible interaction
of AAV and HPV also in vivo is suggested by the finding
of a coexistence of DNA from both viruses in the same
cervical epithelium and in HPV-associated cervical le-
sions (Walz et al., 1997), and other ‘‘classical’’ helper
viruses seem to be absent in many AAV-containing tis-
sue samples (Malhomme et al., 1997).
Colocalization of AAV and HPV in cervical tissue, along
with helper functions of HPV for AAV replication may lead
to infectious AAV particles in vivo. Therefore, we ana-
lyzed cervical biopsies for the presence of AAV virions.
Here we report the detection of infectious AAV in biop-
sies from (HPV-related) squamous intraepithelial lesions
(SIL) and from biopsies of normal cervical tissue. These
data support the hypothesis that HPV might be a natural
helper for AAV in the genital tract and suggest a possible
sexual transmission of AAV.
RESULTS
Detection of AAV and HPV DNA in biopsies
We analyzed biopsies from 36 SIL patients for the
presence of AAV DNA and virus particles. From 33 pa-
tients, in addition to the biopsy from the lesion we also
obtained a biopsy from adjacent cervical tissue that
showed colposcopically no pathologic changes (normal,
N). In total, we analyzed 69 biopsies, from 36 lesions and
33 normal tissues. Material from all lesions had been
histologically examined previously and characterized as
high-grade SIL. Since AAV DNA has been reported to be
present not only in the cervix but also in other human
tissues including blood (Grossmann et al., 1992; P. Klein-
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Bauernschmitt, personal communication, and O. Mal-
homme, personal communication) we used mouse tis-
sue for control purposes. Tissue samples (e.g., liver)
from mice infected systemically with AAV and sacrificed
16 h after infection were analyzed in the same way as the
human biopsies. As negative controls, we used biopsies
from uninfected mice.
All biopsies were homogenized and AAV-specific PCR
analysis of the crude extracts was performed. AAV-pos-
itive samples were further analyzed for the presence of
AAV particles and the presence of HPV DNA (types 16,
18) by PCR.
Twenty-three of the 36 patients were positive for AAV
DNA by PCR analysis of the crude extracts (from N or
SIL, see also Fig. 1). In 8 of the 23 AAV-positive patients,
AAV DNA was found in the lesions (SIL) and was absent
in normal tissue. For 7 patients AAV DNA was detected in
the lesions and in the normal tissue. Eight patients had
AAV DNA in normal tissue but not in the lesion (Fig. 1 and
Table 1).
We then analyzed (by PCR) the biopsies from the 23
AAV-infected individuals for the presence of DNA from
HPV types 16 and 18. Five SIL biopsies from patients
infected with AAV contained HPV 16 DNA and 1 biopsy
contained HPV 18 DNA. No HPV DNA was found in
biopsies from normal tissue of the AAV DNA-positive SIL
patients.
Detection of AAV particles
We further analyzed the AAV DNA-containing biopsies
for the presence of AAV particles. Therefore, we per-
formed CsCl density gradient centrifugation on AAV
DNA-positive tissue extracts to allow separation of viral
particles from free viral DNA. In 11 of 23 AAV DNA-
positive biopsies AAV DNA was detected by PCR after
disruption of particles in fractions with the density cor-
responding to the density of AAV virions (Fig. 2).
In 5 AAV DNA-negative biopsies no AAV particles
could be detected after CsCl centrifugation (data not
shown).
To eliminate false-positive PCR reactions that resulted
from free, nonencapsidated AAV DNA contaminating the
preparations, we treated CsCl fractions with DNase I
FIG. 1. Detection of AAV DNA in cervical biopsies by PCR. Southern
blot analysis of crude extracts (squamous intraepithelial lesions, SIL,
and normal cervical tissue from the same person, N) tested for the
presence of AAV DNA by PCR. Samples positive for AAV DNA are
indicated by underlined biopsy numbers. The 1 indicates biopsies
containing HPV 16 DNA (PCR), and 11 indicates that the SIL biopsy
was PCR-positive for HPV 18 DNA. As positive control for the AAV, 1 pg
and 10 fg of AAV insert DNA were used as template. In the negative
control, no template was added (left lanes).
TABLE 1
Frequency of AAV DNA and/or Virions and/or HPV DNA in Biopsies from AAV-Infecteda SIL Patients
Tissue AAV DNA
HPV 16
DNA
HPV 18
DNA
AAV DNA 1
HPV 16 DNA
AAV
particles
Infectious
AAV
AAV virions 1
HPV DNA
Nb 8 0 0 0 1 2 0
SILc 8 5 1 5 2 2 3
SIL 1 Nd 7 0 0 0 4 3 0
( 23 5 1 5 7 7e 3
a Of 36 patients tested for AAV DNA, 13 were AAV DNA negative.
b Biopsy specimen from colposcopically normal cervical tissue.
c Biopsy specimen from squamous itraepithelial lesion.
d Cases in which N and SIL were positive for AAV DNA and/or particles, as indicated.
e In the biopsies (SIL and N) from one patient AAV particles were detected but only the particles retrieved from the N biopsy were infectious (see
also Fig. 3).
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after dialysis. To control the DNase I treatment we added
AAV DNA and DNase I to negative fractions (see Fig. 2).
Two patients had AAV particles in the SIL but not in the
adjacent normal tissue. One patient had AAV particles in
the normal tissue but no AAV was present in the AAV
DNA-containing lesion. In four patients AAV particles
were detected in both the lesion and the normal tissue
(Table 1).
In summary, we could detect AAV particles in biopsies
from 7 of 23 AAV DNA-positive patients (in a total of 11
biopsies, N and/or SIL).
As mentioned above, we detected HPV 16 DNA in SILs
from five patients and HPV 18 DNA in an SIL of one
patient. We were able to detect AAV virions in the SILs of
three of the five HPV 16-infected and AAV DNA-positive
patients.
The liver tissue from the AAV infected mouse but not
that from an uninfected animal contained AAV virions as
detected by the same method.
AAV virions isolated from human biopsies
are infectious
In order to analyze whether the AAV particles detected
in the biopsies were infectious, we inoculated positive
fractions of the gradients, after treatment with DNase I,
on HeLa cell cultures and subsequently superinfected
the cultures with adenovirus type 2.
In this assay, only cell cultures inoculated with infec-
tious AAV particles replicate AAV DNA in the presence of
adenovirus helper functions. To analyze viral DNA repli-
cation, we extracted low-molecular-weight DNA from the
cells using the Hirt method and visualized the replicative
AAV DNA intermediates by the Southern blot technique.
The results demonstrate replication of AAV DNA in cul-
tures inoculated with samples of gradients in 10 of the 11
AAV particle-containing biopsies (Fig. 4). The particles
from one gradient (No. 11) were not infectious or below
detection level.
In a further approach we used the ‘‘dispersed cell
assay’’ to analyze infectious virus from the fractions.
Three to 4 days after inoculation of HeLa cell cultures
with fractions and subsequent adenovirus infection, cells
were harvested and the whole cellular DNA was trans-
ferred onto a nylon membrane. AAV DNA was visualized
by the Southern blot technique with radiolabeled AAV
DNA as hybridization probe.
The results showed DNA amplification by replication
only in the culture inoculated with AAV-containing frac-
tions from the gradient of biopsy 12 and in the culture
incubated with fractions from the liver biopsy of the
mouse infected with AAV (Fig. 3). These results show that
samples from an AAV-infected mouse contained suffi-
cient numbers of AAV virions to be detected in this assay
and on the other hand show that the biopsy 12 contained
FIG. 2. Detection of AAV particles by CsCl centrifugation. Southern blot of a PCR analysis of CsCl fractions of a representative cervical biopsy.
Fractions containing AAV particles have a buoyant density of 1.41 to 1.45 g/ml, corresponding to the density of AAV virions. (Density of the fractions
is depicted above the autoradiogram.) As indicated (left part of the Southern blot), positive controls were 10 fg and 1 pg of AAV insert DNA. For control
of the DNase I we digested 1 pg of AAV DNA with DNase I. As negative control we added DNase I without DNA. As a positive control we performed
PCR on virus particles and AAV DNA or particles alone. Furthermore, to avoid residual activity of the DNase I after heat inactivation we added 10 fg
of template after inactivation (inakt.)
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sufficient amounts of AAV to be detected with this assay
as well. However, other AAV virion-containing gradients
did not show detectable replication in the dispersed cell
assay, indicating a very low number of infectious virions
in the biopsies.
The results demonstrate that the AAV particles in cer-
vical biopsies from patients with SIL are infectious but
are present in very low abundance.
In summary, the cervical tissue of 23 of 36 patients
was infected with AAV (AAV DNA detected by PCR). In
biopsies from 7 of these 23 AAV-infected patients we
could detect AAV particles. In 4 cases particles were
found in biopsies from the lesion and in biopsies from
normal tissue from the same person; in 2 patients parti-
cles were found only in the lesions and in 1 patient only
in normal tissue. In conclusion, 11 biopsies contained
AAV virions and from these 10 contained infectious AAV.
However, 1 biopsy contained AAV particles that were not
infectious.
Samples from the crude extracts from the 23 patients
infected with AAV were analyzed by PCR for the pres-
ence of HPV types 16 and 18. From 23 AAV-infected SIL
patients 5 were positive for HPV 16 DNA and 1 for HPV
18 DNA. Three patients who had AAV particles in the SIL
were also infected with HPV 16. In the HPV 18-containing
lesion no AAV DNA could be detected.
DISCUSSION
We have previously reported, that AAV DNA is fre-
quently present in biopsies of the uterine cervix (Tobi-
asch et al., 1994). Recently, these data could be con-
firmed by analysis of cervical brushings by Han et al.
(1996). Furthermore, we showed that AAV gene expres-
sion is detectable in koilocytes (Walz et al., 1997), which
are the typical morphological phenotype of HPV-infected
epithelial cells (Meisels et al., 1983). This demonstrates
a close spatial relationship of the two viruses. We could
isolate replication-competent AAV DNA from frozen biop-
sies and even from paraffin-embedded tissue sections,
showing that genomic AAV DNA is present in genital
tissue (Walz et al., 1997).
In the present study we analyzed biopsies from
women with squamous intraepithelial lesions for the
presence of AAV and HPV infection, confirming our ear-
lier reports of the high prevalence of AAV infection in the
uterine cervix (Tobiasch et al., 1994; Walz et al., 1997).
Biopsies from 23 of 36 patients were found to contain
AAV DNA. We are aware of the possibility of contamina-
tion in PCR analyses: Other AAV-infected genital epithe-
lia might be one source of contamination during the
extraction of the biopsies; another might be blood, as
indicated by the data from Grossman et al. (1992), even
if the frequency of infected blood samples is very low.
However, we describe for the first time the detection of
infectious AAV virions in cervical biopsies. As shown by
the results from the dispersed cell assay, only a low
number of AAV virions is present in the biopsies. It has
been shown earlier by in situ hybridization on paraffin-
embedded samples of cervical tissue that only a very low
FIG. 3. Detection of infectious AAV in cervical specimens. Southern blot of low-molecular-weight DNA (Hirt extraction) from adenovirus-infected
HeLa cells inoculated with CsCl fractions (cf. Fig. 2) from biopsies (SIL or normal) from three representative patients. The presence of infectious AAV
virions in the inoculum is revealed by the appearance of replicative AAV DNA intermediates, generated in HeLa cells with helper adenoviruses.
(Sample 11 SIL shows AAV DNA-positive gradient fractions, apparently not containing infectious virus.)
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number of cells contain AAV sequences (Walz et al.,
1997).
The presence of only a few AAV virions in the tissues
might be one reason why AAV-related changes like cell
lysis, as previously observed in cell culture (Walz et al.,
1997), or tissue destruction were not observed by the his-
tologist. Our findings should incite further studies on pos-
sible morphological changes in restricted areas of biopsies
or in specific cells, due to AAV and HPV infection.
The presence of AAV virions in cervical biopsies indi-
cates a possible sexual transmission of AAV and further
implies that an infection of the cervical epithelium with
AAV and a coinfection with HPV could lead to replication
of AAV DNA and production of progeny AAV virions.
Experiments are needed to analyze whether in addi-
tion AAV integrates its genome into the host cell DNA in
the absence of a helper virus or infects cells that carry
HPV genomes and start a new round of replication and
virion production.
In earlier results from in vitro assays, we showed that
HPV 16 is indeed able to provide helper functions for AAV
replication in cell culture: Keratinocytes infected with
AAV were transfected with HPV DNA, leading to replica-
tion of the AAV genomes and AAV virion production (Walz
et al., 1997).
Our present study showed HPV 16 DNA in some of the
lesions that carried AAV DNA and in three of these
lesions infectious AAV virions were found (see Table 1).
These present data showing AAV virions in human cer-
vical biopsies from SIL patients indicate that HPV helper
activity might also function in vivo. The presence of other
genital HPV types (e.g., types 6, 11, 33) together with AAV
in cervical biopsies will have to be determined in further
analyses.
Adenovirus has been described as helper for AAV by
coinfecting cultured cells of different origin (Carter and
Laughlin, 1983; Janik et al., 1981; Laughlin et al., 1982;
Richardson and Westphal, 1984). Other helpers of AAV
including herpes simplex virus types I and II (Mishra and
Rose, 1990; Weindler and Heilbronn, 1991; Buller et al.,
1981), cytomegalovirus (McPherson et al., 1985), and
vacciniavirus (Schlehofer et al., 1986) were found to pro-
vide AAV helper functions in vitro. In recent studies
Malhomme et al. (1997) could not detect adenovirus,
cytomegalovirus, or herpesvirus coinfection in AAV-con-
taining specimens from the cervix uteri, the endome-
trium, or abortion material, suggesting that these viruses
are possibly less important as helpers for AAV in the
genital tract. Therefore, in view of our findings in this
study, it is suggestive that HPV may act as a helper for
AAV replication and particle production in vivo (Her-
monat, 1989; Rabreau and Schlehofer, 1995). The fact
that not only AAV DNA but also infectious AAV virions
were detected in cervical biopsies suggests a possible
sexual transmission of AAV, perhaps along with the hor-
izontal infection with genital HPV types. Furthermore, this
FIG. 4. Dot blot analysis of adenovirus-infected HeLa cells, inoculated with biopsy fractions (cf. Fig. 3). Only one biopsy (No. 12) contained sufficient
AAV virions to yield enough virus to spread within the cell culture to a detectable level. Sample 47 is material from an AAV-infected mouse, sample
48 from an uninfected mouse (internal controls). As control for the helper virus, HeLa cells were infected with serial dilutions (1:10) of adenovirus
(leftmost row of wells, 1 indicating wells with visible CPE after 3 days.
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implies that AAV could subsequently infect cells of the
endometrium and even embryonal tissues, as has been
reported elsewhere (Tobiasch et al., 1994; Malhomme et
al., 1997).
The role of certain HPV types in the causation of
anogenital lesions and cancer of the uterine cervix is
well established (Gissmann, 1992; zur Hausen, 1987,
1991). A subset of these HPV types, including types 16,
18, 31, 33, and 45, are associated with over 95% of all
cervical cancers (Bosch et al., 1995; Matsukura and Su-
gase, 1995).
It has been reported that AAV infection interferes with
tumor development (for review, cf. Schlehofer, 1994).
Most interesting are results from seroepidemiologic
studies showing that cervical cancer patients exhibit
antibodies to AAV less frequently than healthy control
individuals (Mayor et al., 1976; Georg-Fries et al., 1984;
Sprecher-Goldberger et al., 1971). Several studies
showed that AAV infection inhibits cellular transforma-
tion by BPV-1 and HPV 16 (Hermonat, 1989, 1994, 1992;
Hermonat et al., 1997) as well as HPV 18 (Ho¨rer et al.,
1995). Some of these effects could be shown to be
mediated by the AAV Rep 78 protein (Hermonat, 1992;
Hermonat et al., 1997) down-regulating the expression of
the papillomavirus oncogenes. In addition, it could be
shown that Rep 78 is also able to inhibit the expression
of heterologous genes like c-Ha-ras or the HIV long
terminal repeats (Katz and Carter, 1986; Ho¨rer et al., 1995;
Hermonat, 1991; Hermonat et al., 1996, 1997; Rittner et al.,
1992). Furthermore, a recent report showed that AAV Rep
78 interacts with the cellular transcription factor SP1,
thus down-regulating SP1-mediated promoter activity
(Hermonat et al., 1996).
We speculate that coinfection of cells in the cervical
epithelium with specific HPV types and AAV may lead to
AAV replication and AAV virus production and probably to
a cytopathic effect and cell death, as we have shown for
HPV type 16 (Walz et al., 1997). Other types, including
HPV 33, 11, and 6, that also infect the cervical epithelium
still have to be analyzed for their interaction with AAV.
In the absence of helpers, infection with AAV probably
results in integration of AAV genomes into the cellular
DNA, as suggested by in vitro studies (Kotin et al., 1990;
Samulski et al., 1991; Walz and Schlehofer, 1992). Persis-
tent AAV infection could be reactivated (rescue) by sub-
sequent infection with HPV, leading to progeny AAV pro-
duction and possibly to lysis of HPV-infected cells. This
may preclude malignant transformation of the respective
cells.
The explanation for the presence of AAV in SILs which
are premalignant lesions induced by HPV might be the
fact that not all cells have been infected by AAV. It is still
not known if other than epithelial cells of the cervix are
persistantly infected by AAV in the genital tract and
further analyses including AAV- and HPV-specific in situ
hybridization and immunohistochemistry are needed to
show individual cells that are coinfected with both vi-
ruses and are replicating AAV DNA.
It seems of great importance to investigate the further
progress of the SIL in each individual patient. This might
show whether lesions of AAV-infected patients tend to
regress at a higher frequency than those of uninfected
patients.
MATERIAL AND METHODS
Cell culture
Cells of the cervical carcinoma cell line HeLa and
HeLa-derived cells containing integrated AAV-2 DNA
(HA 16, Walz et al., 1992) were cultivated in Eagle’s
minimal essential medium (Dulbecco modification, D-
MEM, GIBCO, Bethesda, MD) supplemented with 10%
fetal calf serum (FCS, GIBCO) and penicillin/streptomy-
cin (100 u/ml/100 mg/ml), at 37°C, 5% CO2, in a humidi-
fied atmosphere.
Virus
Adeno-associated virus type 2 (AAV-2) was propa-
gated in HeLa cells by coinfection with adenovirus type
2 (Ad-2), purified, and titrated as described previously
(Yacobson et al., 1987; Walz et al., 1992). Adenovirus type
2 was purchased from ATCC (Rockville, MD).
Plasmids
The genomic AAV DNA insert of the plasmid pTAV2
(Heilbronn et al., 1990) was used for radiolabeled probes
and for PCR controls. For HPV 16 probe, we used the
complete viral genomic DNA, excised from the vector by
cleaving with BamHI restriction enzyme (Du¨rst et al.,
1983). For hybridization, DNA radiolabeling was per-
formed with [a-32P]dCTP (Amersham, Arlington Heights,
IL) using the random priming technique (Feinberg and
Vogelstein, 1996).
Biopsies
From 36 patients, specimens from squamous intraepi-
thelial lesions (SIL, Anonymous, 1988) and from adjacent
normal epithelium were frozen in liquid nitrogen after
extraction. From 3 patients, only biopsies from the lesion
were available. Material from all samples was patholog-
ically characterized. The biopsies were about 1–3 mm3 in
size. As positive controls for AAV-containing samples, we
used liver biopsies from AAV-infected mice 16 h postin-
fection (since in previous analyses with AAV-infected
mice we had shown that AAV DNA could be detected in
blood samples up to 2 days after intravenous infection
(Walz et al., 1992).
PCR
As negative controls in PCR analyses, tissue biopsies
from uninfected mice were used. All biopsies were han-
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dled separately in an AAV- and HPV-free sterile work
bench. If possible, we used disposable material for treat-
ment of biopsies; all other materials (e.g., glass homog-
enizers) were washed with 36% HCl and 5% SDS, rinsed
with 100% ethanol, and finally autoclaved to avoid cross
contamination.
For detection of AAV 2 DNA, the following primers
were used (Han et al., 1996): AAV-2: No. 1—59CAT CGC
GGA GGC CAT AGC CC-39 (nt 1346 to 1365); No. 2—59-
ACG GGA GTC GGG TCT ATC TG-39 (nt 1567 to 1548). For
amplification, we used a Perkin–Elmer GeneAmp 2400
programmed for 1 cycle at 95°C for 5 min, 35 cycles of
40 s at 94°C, 40 s at 63°C, and 30 s at 75°C and a final
cycle for 10 min at 75°C. Amplification resulted in a
product of 221 bp. As positive controls of the PCR, we
used 10 fg and 1 pg of AAV DNA (pTAV2, cf. above).
HPV-specific primers were used according to van den
Brule et al. (1990): HPV 16: No. 1—59-TGC TAG TGC TTA
TGC AGC AA-39 (L1, nt 6028 to 6047); No. 2—59-ATT TAC
TGC AAC ATT GGT AC-39 (L1, nt 6160–6179).
HPV 18: No. 1—59-AAG GAT GCT GCA CCG GCT
GA-39 (L1, nt 6903 to 6922); No. 2—59-CAC GCA CAC
GCT TGG CAG GT-39 (L1, nt 7100 to 7119).
For amplification we performed 1 cycle at 95°C for 4
min, 30 cycles of 1 min at 95°C, 2 min at 55°C, and 1 min
30 s at 72°C, and 1 cycle at 72°C for 5 min. As positive
control of the PCR reaction, we used 10 fg of genomic
HPV DNA of the respective types.
As negative control for each PCR reaction we used the
PCR reaction mix containing the respective primers lack-
ing template DNA.
PCR products were separated by electrophoresis on a
1% agarose gel, transferred to a Nylon membrane by the
Southern blot technique, and immobilized by UV
crosslinking. Blots were hybridized with radiolabeled
genomic AAV or radiolabeled HPV DNA and exposed to
X-ray film.
Virion extraction from biopsies
Biopsies were cut into small pieces and incubated at
37°C for 30 min in 10 ml of 140 mM NaCl, 5 mM KCl, 0.7
mM K2HPO4, 25 mM Tris–HCl, pH 7.4, after adding 500 ml
10% sodium deoxycholate. Thereafter, the lysates were
homogenized with a glass homogenizer type A (20
strokes), and 5 ml of the homogenate was boiled for 10
min and tested using AAV PCR as described below.
AAV-containing lysates were further analyzed for the
presence of HPV DNA by PCR.
CsCl (6.5 g) was added to 10 ml homogenate of the
AAV DNA-positive samples (PCR) and five representative
AAV DNA-negative samples for control purposes. After
dissolving of the cell homogenate, the refraction index
was determined and adjusted to 1.372 OD.
Ultracentrifugation was performed at 38,000 rpm at
20°C for 26 h in a TH641 (Sorvall) swinging bucket rotor.
The gradients were fractionated (about 200–300 ml per
fraction) from the bottom using a syringe needle. Density
of the fractions was measured using a refractometer
(AAV particles band at a CsCl density of 1.40 g/ml, HPV at
1.32 g/ml) (Cukor et al., 1984; Crawford and Crawford,
1993). The fractions were dialyzed against PBS (or 1 M
NaCl) at room temperature for 30 min. To avoid contam-
ination with nonencapsidated AAV DNA in the samples,
dialyzed aliquots of the fractions were treated with
RNase-free DNase I (Boehringer, Mannheim Germany)
prior to PCR [10 ml dialyzed fraction sample, 5 ml MgCl2
(25 mM) and 20 u of DNase in a final volume of 50 ml]
overnight at room temperature. To inactivate DNase and
to release the viral DNA from the capsids, samples were
boiled for 15 min. Five microliters of each fraction was
then used for HPV and AAV 2-specific PCR, respectively.
Identification of infectious AAV virions
The presence of infectious AAV particles was tested in
a standard cell culture assay using adenovirus 2 (Ad-2)
as a helper for AAV replication. Dialyzed samples of the
gradients were incubated with HeLa cells for 45 min at
37°C. Cultures were then infected with Ad-2 (m.o.i. 5 1
PFU per cell) and again incubated for 30 min at 37°C.
Finally, medium was added and the cells were cultured
until a complete cytopathic effect of the adenovirus was
visible. The cultures were subjected to three freeze and
thaw cycles and replication of infectious virus in the
inoculum was visualized by analysis of AAV DNA ampli-
fication.
Hirt extraction. To analyze the viral DNA replication we
used the cell culture assay described above. When the
complete cytopathic effect of Ad-2 was visible, cultures
were harvested and centrifuged at 500 g for 15 min. The
cell-free supernatant was transferred onto subconfluent
HeLa cells in 35-mm dishes and cultured for 24 h. Cul-
ture samples were washed twice with PBS and low-
molecular-weight DNA was extracted according to Hirt
(1967). Ten micrograms of low-molecular-weight DNA
was separated by agarose gel electrophoresis and
transferred onto Nylon membranes. Immobilized DNA
was hybridized with radiolabeled AAV-2 DNA and ex-
posed to X-ray films. As a molecular size marker we used
l DNA digested with HindIII. As a negative control for the
Southern blot we applied DNA from HeLa cells digested
with EcoRV. As a positive control low-molecular-weight
DNA from either adenovirus-infected HA 16 cells (persis-
tently AAV-infected HeLa cells) or from HeLa cells coin-
fected with AAV and adenovirus was used. DNA from
HeLa cells infected with adenovirus was used as con-
trol for a possible contamination of the adenovirus stock
with AAV.
Dispersed cell assay. After freeze–thawing of cultures,
inoculated as described above, samples were trans-
ferred onto a nylon membrane by suction. Replication of
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AAV DNA was measured by hybridization with a radiola-
beled AAV probe. Signals on the film indicated amplifi-
cation of viral DNA, thus showing the presence of infec-
tious AAV particles in the fractions inoculated onto cells.
Infection of HeLa cells by adenovirus alone was used as
a negative control, with AAV of known titer plus adeno-
virus coinfection as a positive control.
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